Key result
Adding LVA ablation to PVI cuts AF/AT recurrences by ~47% versus PVI alone.
Why the study?
Does voltage-guided substrate modification targeting low-voltage areas in addition to PVI improve freedom from AF/AT recurrences in patients undergoing catheter ablation for AF?
Meta-Analysis (n=885)
Does voltage-guided substrate modification targeting low-voltage areas in addition to PVI improve freedom from AF/AT recurrences in patients undergoing catheter ablation for AF?
Targeting low-voltage areas in addition to PVI during AF ablation significantly improves freedom from atrial arrhythmias without increasing adverse events compared to conventional approaches.
Answers are grounded in this paper and cite their sources.
Supports adding LVA ablation to PVI for higher AF/AT freedom; extends prior trial data via meta-analysis.
BACKGROUND: This meta-analysis aims to assess the impact of a voltage-guided substrate modification by targeting low-voltage area (LVA) in addition to pulmonary vein isolation (PVI) in patients undergoing catheter ablation for atrial fibrillation (AF). METHODS: MEDLINE/PubMed, Cochrane Library, and references reporting AF ablation and "voltage* OR substrate* OR fibrosis OR fibrotic area*" were screened and studies included if matching inclusion and exclusion criteria. RESULTS: Six studies were included. Patients enrolled were 885 (517 in the study group and 368 in the control group). Median age was 60 years; 92% had nonparoxysmal AF. At a mean follow-up of 17 months, 70% of patients in the study group vs. 43% in the control group were free from AF/atrial tachycardia (AT) recurrences (odds ratio [OR] = 3.41, 95% confidence interval [CI] 2.22-5.24). LVA ablation in addition to PVI was more effective than PVI alone and PVI + conventional wide empirical ablation (70% vs. 43%, OR = 3.41, 95% CI 2.22-5.24), without increasing the adverse event rate (2.5% vs. 6%, OR = 0.43, 95% CI 0.15-1.26). Compared to PVI + conventional wide empirical ablation, LVA ablation reduced the occurrence of postablation AT (14% vs. 46%, OR = 0.16, 95% CI 0.07-0.37), procedure time (176 min vs. 220 min, OR = 0.36, 95% CI 0.24-0.56), fluoroscopy time (25 min vs. 31 min, OR = 0.22, 95% CI 0.12-0.39), and radiofrequency time (55 min vs. 90 min, OR = 0.49, 95% CI 0.27-0.90). CONCLUSIONS: A voltage-guided substrate modification by targeting LVA in addition to PVI is more effective, safer, and holds a lower proarrhythmic potential than conventional ablation approaches. Further randomized studies are necessary to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Blandino et al. (2017) conducted a meta-analysis in Atrial fibrillation (n=885). Voltage-guided substrate modification targeting low-voltage area (LVA) in addition to PVI vs. PVI alone and PVI + conventional wide empirical ablation was evaluated on Freedom from AF/atrial tachycardia (AT) recurrences (OR 3.41, 95% CI 2.22-5.24). LVA ablation in addition to PVI increased freedom from AF/AT recurrences compared to PVI alone or with conventional ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: